ADVANCE Staff | October 31, 2011 Editor’s note: We’re pleased to introduce this new series, Industry Views, to provide an inside look at technological changes and developments in the clinical laboratory. ADVANCE talks with TJ Johnson, CEO of HTG Molecular Diagnostics, about the future of the clinical laboratory.